Markets remain near all-time highs in 2026 despite extreme valuations and multiple warning signals. Click here for more ...

There are some languages that don't need mass appeal to be loved. Elixir, Lua, Zig, Clojure, Julia, and Rust prove that point ...

Interest is growing in whether Kevin Warsh, the nominee for the next Federal Reserve Chair, is correct in his view that ...

Vladimir Zakharov explains how DataFrames serve as a vital tool for data-oriented programming in the Java ecosystem. By ...

In the panic after 9/11, the US swept hundreds of men into Guantánamo – most not terrorists at all – and built a system that could not admit its own failure, writes human rights lawyer Eric Lewis in t ...

Apple today updated its Final Cut Pro and Logic Pro apps, and there are many new features in both the one-time purchase and Apple Creator Studio versions. Here is what is new in all versions of Final ...

Tech-enabled clinical research platform Paradigm Health has secured $78 million in an oversubscribed Series B financing round and announced its acquisition of oncology-focused digital health company ...

Paradigm Health has raised $78 million as it works to revamp the clinical research ecosystem, while also announcing a deal to acquire Flatiron Health's clinical research business unit. With the ...

Matthew Herper covers medical innovation — both its promise and its perils. When people talk about using artificial intelligence to transform the way medicines are studied, they often imagine ...

Logical fallacies are flaws in reasoning. They are often called informal fallacies. It's becoming more common for people to call out these fallacies by name. You often hear accusations of people ...

Sharing a database is the greatest sin when you architect Microservices yet Space-Based Architecture is built around shared data. How do these approaches coexist? Do Microservices make any sense if ...

Over 31 million people suffer from osteoarthritis in the United States alone, including a high number of retired professional athletes. Paradigm Biopharmaceuticals (ASX: PAR) has struck a strategic ...